Cyclacel Pharmaceuticals, Inc. (BGMS)
Market Closed
16 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 82
-0.01
-1.2048%
$
1.96M Market Cap
- P/E Ratio
- Div Yield
109,378 Volume
- Eps
$ 0.83
Previous Close Want to track BGMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BGMS Earnings Reports FAQ
What is the earnings per share (EPS) for BGMS?
EPS data for BGMS is currently not available, as Cyclacel Pharmaceuticals, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Cyclacel Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Cyclacel Pharmaceuticals, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Cyclacel Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for BGMS at this time, as Cyclacel Pharmaceuticals, Inc has no recent EPS data to calculate it.
